今日推薦開源項目：《spring-boot-demo》
今日推薦英文原文：《FDA panel backs Pfizer's COVID-19 vaccine for emergency use in US》
今日推薦開源項目：《spring-boot-demo》傳送門：項目鏈接
推薦理由：spring boot demo是一個用來深度學習並實戰spring boot的項目，目前總共包含一個66集成demo，已經完成54個。 該項目已成功集成驅動器（監控），admin（可視化監控），logback（日誌），aopLog（通過AOP記錄web請求日誌），統一異常處理（json級別和頁面級別），freemarker（模板引擎），thymeleaf（模板引擎），Beetl（模板引擎），Enjoy（模板引擎），JdbcTemplate（通用JDBC操作資料庫），JPA（強大的ORM框架） ，mybatis（強大的ORM框架），通用Mapper（快速操作Mybatis），PageHelper （），mybatis 通用的Mybatis分頁插件-plus（快速操作Mybatis），BeetlSQL（強大的ORM框架），upload（本地文件上傳和七牛雲文件上傳），redis（緩存），ehcache（緩存），email（發送各種類型郵件），task（基礎定時任務），quartz（動態管理定時任務），xxl- job（分散式定時任務），swagger（API介面管理測試），security（基於RBAC的動態許可權認證），SpringSession（Session共享），Zookeeper（結合AOP實現分散式鎖），RabbitMQ（消息隊列），Kafka（消息隊列），websocket（服務端推送監控伺服器運行信息），socket.io（聊天室），ureport2（中國式報表），打包成war文件，集成ElasticSearch（基本操作和高級查詢） ，Async（非同步任務），IntegratedDubbo（採用官方的starter），MongoDB的（文檔資料庫），Neo4j的（圖資料庫），搬運工（容器化）， ，JPA多數據源，Mybatis多數據源，GrayLog（代碼生成器 日誌收集），JustAuth（），LDAP（第三方登錄 增刪改查），，動態添加/切換數據源單機限流（AOP + Guava RateLimiter），分散式限流（AOP + Redis + Lua），ElasticSearch 7.x的（使用官方 Rest High Level Client）， HTTPS，Flyway（資料庫初始化）。
今日推薦英文原文：《FDA panel backs Pfizer's COVID-19 vaccine for emergency use in US》作者：Abrar Al-Heeti
原文鏈接：https://www.cnet.com/news/fda-panel-backs-pfizers-covid-19-vaccine-for-emergency-use-in-us/
推薦理由：疫情仍在美國肆虐, 疫苗的開發進度也是全球範圍內的焦點. 美國食品和藥物管理局的一個諮詢小組周四正式提出輝瑞公司在美國的疫苗具有緊急使用授權, 若得到授權該疫苗可在幾天之內在美國推出。
FDA panel backs Pfizer's COVID-19 vaccine for emergency use in US
A US Food and Drug Administration advisory panel on Thursday formally recommended emergency use authorization for Pfizer's COVID-19 vaccine in the United States. If the FDA chooses to accept the recommendation, the vaccine could be rolled out in the US within days.Pharmaceutical giant Pfizer, which developed the vaccine with German partner BioNTech, said last month that the vaccine demonstrated 95% effectiveness in clinical trials. The companies applied for emergency use authorization from the FDA in late November. A review published by the FDA on Tuesday confirmed that the vaccine meets the standard for emergency use authorization.
The recommendation came out of a daylong FDA meeting Thursday. An independent panel of experts, known as the Vaccines and Related Biological Products Advisory Committee, has been discussing the Pfizer vaccine in detail.
Pfizer and BioNTech have conducted human trials on more than 43,000 people in six countries. They initially reported more than 90% effectiveness for the vaccine, before a final data analysis found that it was 95% effective in preventing COVID-19, with no serious side effects.
The Pfizer vaccine -- as well as another from US drug developer Moderna, which is said to be 94% effective -- is an experimental RNA vaccine. It uses synthetic messenger RNA, or mRNA, a molecule that tells cells how to build proteins. It can then trick cells into producing proteins typically found in SARS-CoV-2, the virus that causes COVID-19, which in turn can then stimulate the immune system -- without making patients sick -- to protect against infection. Moderna has also applied for FDA emergency approval for its coronavirus vaccine.
Given that there are more than 330 million people in the US, not everyone will be able to get the vaccine right away. Health care workers will be prioritized, as well as people at higher risk of infection due to age, underlying conditions or profession.
Administering the coronavirus vaccine
On Tuesday, the UK became the first country to start administering the Pfizer COVID-19 vaccine, following clinical approval. The first person to receive the vaccine outside of a clinical trial was 90-year-old Margaret Keenan, who was given the first of two injections needed. Four million people in the UK are expected to begin the process by the end of December. Canada approved Pfizer's vaccine on Wednesday. There are several dozen coronavirus vaccines in various stages of clinical trials, with some almost ready to be submitted for potential authorization. Most experts say we'll have many more ready to distribute by early 2021.
In a panel earlier this week, Dr. Anthony Fauci, director of the US National Institute of Allergy and Infectious Diseases, said the sooner the United States can convince the overwhelming majority of people to get vaccinated, the sooner things will be "close to normal."
The first cases of COVID-19 were reported in China a year ago this month. By March, a pandemic was in full force. According to the Johns Hopkins coronavirus dashboard, more than 69 million cases have been confirmed worldwide and nearly 1.6 million people have died of COVID-19 as of Thursday.
下載開源日報APP：https://openingsource.org/2579/
加入我們：https://openingsource.org/about/join/
關注我們：https://openingsource.org/about/love/
